|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance of $1,060 and $980, respectively | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Receivable from former related party | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $864 and $785, respectively | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Revolving line of credit, net of capitalized financing costs of $201 | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Senior secured loan, net of deferred financing costs of $23 and $68, respectively | ||||||||||||||||||||
| Payable to former related party | ||||||||||||||||||||
| Current portion of convertible notes payable, net of debt discount of $424 | ||||||||||||||||||||
| Current portion of lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| SAFE agreements | ||||||||||||||||||||
| SAFE investments | ||||||||||||||||||||
| Convertible note payable, net of debt discount of $148 less current portion | ||||||||||||||||||||
| Lease liabilities, less current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies | ||||||||||||||||||||
| Stockholders’ equity (deficiency): | ||||||||||||||||||||
| Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $.0001 par value, 60,000,000 shares authorized; 11,857,086 and 11,820,429 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity (deficiency): | ||||||||||||||||||||
| Total liabilities and stockholders’ equity (deficiency): | ||||||||||||||||||||
Loading...
